Back to search

Virginia Commonwealth University

Maintaining Legitimacy While Managing Competition: Do Transplant Survival Ratings Affect Kidney Transplant Waitlisting?

Abstract

dc:description.abstract

Statement of problem and objectives: Waitlisting is an essential step towards kidney transplantation among people with end-stage kidney disease (ESRD). There are no universal standards for waitlisting ESRD patients and how waitlists are managed in kidney transplant programs is opaque and under-studied. This study investigated whether the quality ratings of kidney transplant programs based on their one-year survival rates were associated with waitlist outcomes, including the number of waitlist additions, waitlist removals, the risk profiles of patients added or removed from a kidney transplant program’s waitlist, and whether market competition among kidney transplant programs attenuated these relationships. Procedure followed: This study employed a retrospective, observational design using secondary data from the USRDS, UNOS, and the SRTR to assess the relationships between one-year survival ratings, competition, and waitlist management activities using panel analysis methods. Competition was operationalized via the Herfindahl–Hirschman Index (HHI), and survival ratings were obtained from transplant program PSRs. Results: Lower one-year survival ratings were associated with fewer waitlist additions and more waitlist removals for non-medical reasons. Competition attenuated the relationship between one-year survival ratings and waitlist additions, but not the relationship between ratings and waitlist removals. No association was found between one-year survival ratings, competition, and clinical risk for either waitlist additions or removals. A sensitivity analysis employing multilevel logistic regression on waitlist removals further supported the findings by demonstrating that both patient-level factors and quality ratings independently affected the likelihood of removal, but only one interaction between patient-level clinical risk and quality ratings reached significance: history of drug use. Conclusions: The current quality rating framework may unintentionally restrict access to kidney transplantation. Moreover, waitlist “churn” may be an underrecognized consequence of the current quality rating framework.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Health Administration

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Placona, Andrew
Contributors dc:contributor
  • Shoou-Yih Daniel Lee

Subjects

dc:subject × 4

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Placona, Andrew. Maintaining Legitimacy While Managing Competition: Do Transplant Survival Ratings Affect Kidney Transplant Waitlisting?. Dissertation thesis, https://doi.org/10.25772/n5as-t724